Clínica Baviera, S.A. (BME:CBAV)
50.00
+0.50 (1.01%)
At close: Mar 18, 2026
Clínica Baviera Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5.59 | 10.14 | 8.31 | 19.17 | 9.8 |
Short-Term Investments | 44.83 | 27.59 | 41.46 | 19.29 | 22.47 |
Cash & Short-Term Investments | 50.42 | 37.73 | 49.77 | 38.46 | 32.27 |
Cash Growth | 33.64% | -24.18% | 29.39% | 19.18% | 19.81% |
Accounts Receivable | 4.64 | 4.02 | 2.95 | 2.84 | 3.36 |
Other Receivables | 0.1 | 0.69 | 0.61 | 0.31 | 0.08 |
Receivables | 4.73 | 4.71 | 3.56 | 3.15 | 3.45 |
Inventory | 3.33 | 3.28 | 2.47 | 2.16 | 1.93 |
Other Current Assets | 0.86 | 2 | 1.94 | 0.83 | 0.27 |
Total Current Assets | 59.34 | 47.72 | 57.74 | 44.61 | 37.92 |
Property, Plant & Equipment | 142.48 | 122.66 | 99.06 | 86.08 | 77.25 |
Long-Term Investments | 2.44 | 0.06 | 0.09 | 0.12 | 0.19 |
Goodwill | 29.01 | 28.31 | 14.62 | 14.62 | 14.62 |
Other Intangible Assets | 11.08 | 8.73 | 2.75 | 0.46 | 1 |
Long-Term Deferred Tax Assets | 3.16 | 1.88 | 1.4 | 1.01 | 0.98 |
Other Long-Term Assets | - | 2.2 | 2.81 | 3.03 | 1.65 |
Total Assets | 247.51 | 211.69 | 178.64 | 150.1 | 133.81 |
Accounts Payable | 13.01 | 17.17 | 15.52 | 15.62 | 12.98 |
Accrued Expenses | - | 12.99 | 10.75 | 8.46 | 7.71 |
Current Portion of Long-Term Debt | 2.04 | 1.91 | 2.02 | 2.01 | 4.1 |
Current Portion of Leases | - | 9.32 | 8.64 | 7.83 | 7.46 |
Current Income Taxes Payable | 3.97 | 3.61 | 3.48 | 1.95 | 2.92 |
Other Current Liabilities | 42.45 | 5.44 | 4.85 | 5.17 | 0.69 |
Total Current Liabilities | 61.47 | 50.44 | 45.27 | 41.04 | 35.87 |
Long-Term Debt | 5.89 | 5.29 | 0.5 | 2.52 | 6.47 |
Long-Term Leases | 61.82 | 44.82 | 36.11 | 35.41 | 33.37 |
Long-Term Deferred Tax Liabilities | 1.61 | 0.91 | 0.51 | 0.26 | 0.29 |
Other Long-Term Liabilities | 5.76 | 11.88 | 3.97 | 2.51 | 2.42 |
Total Liabilities | 136.55 | 113.33 | 86.37 | 81.74 | 78.42 |
Common Stock | 1.63 | 1.63 | 1.63 | 1.63 | 1.63 |
Additional Paid-In Capital | 4.89 | 4.89 | 4.89 | 4.89 | 4.89 |
Retained Earnings | 42.06 | 40.53 | 36.3 | 21.69 | 19.56 |
Treasury Stock | -8.42 | -9.14 | -0.11 | -0.09 | -0.08 |
Comprehensive Income & Other | 69.82 | 59 | 48.28 | 39.22 | 28.59 |
Total Common Equity | 109.99 | 96.92 | 91 | 67.34 | 54.6 |
Minority Interest | 0.97 | 1.44 | 1.28 | 1.02 | 0.79 |
Shareholders' Equity | 110.96 | 98.36 | 92.28 | 68.37 | 55.39 |
Total Liabilities & Equity | 247.51 | 211.69 | 178.64 | 150.1 | 133.81 |
Total Debt | 69.75 | 61.33 | 47.27 | 47.77 | 51.4 |
Net Cash (Debt) | -19.32 | -23.6 | 2.49 | -9.31 | -19.13 |
Net Cash Per Share | -1.19 | -1.48 | 0.15 | -0.57 | -1.17 |
Filing Date Shares Outstanding | 16.02 | 15.99 | 16.3 | 16.3 | 16.3 |
Total Common Shares Outstanding | 16.02 | 15.99 | 16.3 | 16.3 | 16.3 |
Working Capital | -2.13 | -2.72 | 12.48 | 3.57 | 2.06 |
Book Value Per Share | 6.87 | 6.06 | 5.58 | 4.13 | 3.35 |
Tangible Book Value | 69.9 | 59.88 | 73.63 | 52.27 | 38.99 |
Tangible Book Value Per Share | 4.36 | 3.74 | 4.52 | 3.21 | 2.39 |
Land | - | 121.66 | 107.33 | 98.87 | 90.13 |
Machinery | - | 134.47 | 113.73 | 91.42 | 94.17 |
Construction In Progress | - | 0.38 | 6.37 | 5 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.